Feasibility of Direct Sputum Molecular Testing for Drug Resistance as Part of Tuberculosis Clinical Trials Eligibility Screening

Feasibility of Direct Sputum Molecular Testing for Drug Resistance as Part of Tuberculosis Clinical Trials Eligibility Screening

A rapid diagnosis of drug-resistant tuberculosis (TB) is critical for early initiation of effective therapy. Molecular testing with line probe assays (MTBDR<i>plus</i> and MTBDR<i>sl</i>) on culture isolates has been available for some time and significantly reduces the time...

Full description

Bibliographic Details
Main Authors: Narges Alipanah, Priya B. Shete, Hanh Nguyen, Nhung Viet Nguyen, Lien Luu, Thuong Pham, Hung Nguyen, Phuong Nguyen, Minh Chi Tran, Nam Pham, Ha Phan, Patrick P.J. Phillips, Adithya Cattamanchi, Payam Nahid
Format: Article
Language:English
Published: MDPI AG 2019-05-01
Series:Diagnostics
Subjects:
MTBDR<i>plus</i>
MTBDR<i>sl</i>
line probe assay
tuberculosis
DR-TB
Hain test
diagnostics
clinical trials
molecular testing
Online Access:https://www.mdpi.com/2075-4418/9/2/56

Internet

https://www.mdpi.com/2075-4418/9/2/56

Similar Items